GlassScriptPhysician profile
Kamran Hussain
NPI 1265634810
$1,458.47
in general payments reported to CMS, 2019-2025
12 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $55.26 · 2021: $275 · 2022: $243 · 2023: $136 · 2024: $501 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $375.96 | 2022-2025 | Infuse |
| Topcon Healthcare, INC. | $213.18 | 2024 | |
| Coopervision INC. | $197.99 | 2024-2025 | Cvi Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $179.93 | 2019-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $162.80 | 2019-2021 | |
| Rxsight INC | $93.75 | 2022 | |
| Novartis Pharmaceuticals Corporation | $88.46 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $39.53 | 2024-2025 | |
| Ivantis, INC | $35.91 | 2021 | |
| Sight Sciences, INC. | $34.58 | 2021 | |
| Iridex Corporation | $20.75 | 2021 | |
| Carl Zeiss Meditec, INC. | $15.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamran Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.